Strides Pharma shares hit 52-week high as companys unit receives USFDA approval for Icosapent Ethyl capsules
Strides Pharma news: Strides Pharma Science announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, received USFDA (United States Food and Drug Administration) approval for Icosapent Ethyl Capsules 0.5 gram and 1 gram.
Strides Pharma share price NSE, Strides Pharma news: Strides Pharma Science shares zoomed over 8 per cent in morning deals on Monday, September 25 to clock a fresh 52-week high of Rs 539 on the NSE, shrugging off weakness in the Nifty Pharma index after the pharma company announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, received USFDA (United States Food and Drug Administration) approval for Icosapent Ethyl Capsules 0.5 gram and 1 gram. The counter traded at Rs 530.05, up 6.28 per cent on NSE at 10:29 am.
Here's how the counter has moved so far:
stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.